Meet Dr. Farshid Araghizadeh
Colon and Rectal Surgeon

 

“People with colorectal disorders often feel scared and helpless and think they won’t be able to have productive, fulfilling lives, or that they will have to wear a colostomy bag. But with all the evidence-based treatments as well as the latest technological advances we offer, it’s really quite the opposite,” says Farshid Araghizadeh, M.D., Chief of Colorectal Surgery at UT Southwestern Medical Center.

A four-time D Magazine Best Doctor, Dr. Araghizadeh expertly treats patients who require surgery for conditions such as colon cancer, rectal cancer, inflammatory bowel disease (IBD) – including ulcerative colitis and Crohn’s disease – as well as diverticulitis and anorectal disorders.

Dr. Araghizadeh is highly experienced in performing a wide range of surgeries, many of which are now offered minimally invasively with laparoscopic, transanal, robotic, and single-incision procedures. Additionally, a number of minor procedures may be performed in his office.

In delivering comprehensive, multidisciplinary care, he works closely with other UT Southwestern specialists that include gastroenterologists and medical and radiation oncologists from the acclaimed Simmons Cancer Center.

Dr. Araghizadeh says ongoing advances in colorectal surgery are making a real difference in the lives of many patients.

“We’re constantly involved in finding ways to improve patient outcomes, and we’re dedicated to using the most current evidence-based treatments and surgeries,” he says.

One example is UT Southwestern’s participation in The OSTRiCh Consortium. Founded in 2011, The OSTRiCh Consortium (Optimizing the Surgical Treatment of Rectal Cancer) is a group of healthcare institutions that have come together with the purpose of improving the outcomes and quality of rectal cancer care in the U.S. through advocacy, education, and research. 

“We hold our surgeons and oncologists responsible for achieving the best patient outcomes established by OSTRiCh and based on national treatment guidelines,” he says.

Dr. Araghizadeh believes the refinement of minimally invasive surgery techniques and the introduction of innovative new procedures, as well as improvements in radiation and chemotherapeutic and newer biologic agents over the past decade are some of the most important advances made in the field of colon and rectal surgery, positively impacting the quality of his patients’ lives.

“One of the most satisfying things about treating patients with colorectal disorders is that we can really help them survive, thrive and to have impactful lives,” he says.